Sacubitril/Valsartan Amber-G Guidance See section 2.5.5
SGLT2 Letter - The DBTHFT Cardiology department may write to ask primary care colleagues to consider prescribing either Empagliflozin or Dapagliflozin to eligible patients with chronic heart failure without requesting permission from or referring for a specialist opinion first, for details of the letter Click here
Chronic heart failure with reduced ejection fraction
Brand : Jardiance
Rationale 1,2
NICE TA929 Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
NICE TA773 Treating chronic heart failure with reduced ejection fraction in adults.
| Pack | Price |
|---|---|
| 28 tablet | £36.59 |
| 30 tablet |
Review Date: 01/03/2026
Dapagliflozin Tablets
Chronic heart failure
Brand : Forxiga
NICE TA902 Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
NICE TA679 Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Dapagliflozin is recommended as an option for treating symptomatic chronic heart failure with reduced ejection fraction only if used as an add-on to optimised standard care outlined in guidance TA679. Dapagliflozin should only be started on advice from a heart failure specialist
| Pack | Price |
|---|---|
| 28 tablet | £36.59 |
| Pack | Price |
|---|---|
| 28 tablet | £36.59 |